C/EBPδ Suppresses Motility-Associated Gene Signatures and Reduces PDAC Cell Migration

Pancreatic Ductal Adenocarcinoma (PDAC) is among the most aggressive human cancers and occurs globally at an increasing incidence. Metastases are the primary cause of cancer-related death and, in the majority of cases, PDAC is accompanied by metastatic disease at the time of diagnosis, making it a p...

Full description

Bibliographic Details
Main Authors: Leonie Hartl, Pien A. F. Maarschalkerweerd, Joe M. Butler, Xue D. Manz, Victor L. J. L. Thijssen, Maarten F. Bijlsma, JanWillem Duitman, C. Arnold Spek
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/11/21/3334
_version_ 1797468804010213376
author Leonie Hartl
Pien A. F. Maarschalkerweerd
Joe M. Butler
Xue D. Manz
Victor L. J. L. Thijssen
Maarten F. Bijlsma
JanWillem Duitman
C. Arnold Spek
author_facet Leonie Hartl
Pien A. F. Maarschalkerweerd
Joe M. Butler
Xue D. Manz
Victor L. J. L. Thijssen
Maarten F. Bijlsma
JanWillem Duitman
C. Arnold Spek
author_sort Leonie Hartl
collection DOAJ
description Pancreatic Ductal Adenocarcinoma (PDAC) is among the most aggressive human cancers and occurs globally at an increasing incidence. Metastases are the primary cause of cancer-related death and, in the majority of cases, PDAC is accompanied by metastatic disease at the time of diagnosis, making it a particularly lethal cancer. Regrettably, to date, no curative treatment has been developed for patients with metastatic disease, resulting in a 5-year survival rate of only 11%. We previously found that the protein expression of the transcription factor CCAAT/Enhancer-Binding Protein Delta (C/EBPδ) negatively correlates with lymph node involvement in PDAC patients. To better comprehend the etiology of metastatic PDAC, we explored the role of C/EBPδ at different steps of the metastatic cascade, using established in vitro models. We found that C/EBPδ has a major impact on cell motility, an important prerequisite for tumor cells to leave the primary tumor and to reach distant sites. Our data suggest that C/EBPδ induces downstream pathways that modulate actin cytoskeleton dynamics to reduce cell migration and to induce a more epithelial-like cellular phenotype. Understanding the mechanisms dictating epithelial and mesenchymal features holds great promise for improving the treatment of PDAC.
first_indexed 2024-03-09T19:11:41Z
format Article
id doaj.art-c40525e5847b4102add33b8dc3094fbd
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-09T19:11:41Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-c40525e5847b4102add33b8dc3094fbd2023-11-24T04:07:04ZengMDPI AGCells2073-44092022-10-011121333410.3390/cells11213334C/EBPδ Suppresses Motility-Associated Gene Signatures and Reduces PDAC Cell MigrationLeonie Hartl0Pien A. F. Maarschalkerweerd1Joe M. Butler2Xue D. Manz3Victor L. J. L. Thijssen4Maarten F. Bijlsma5JanWillem Duitman6C. Arnold Spek7Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam UMC Location University of Amsterdam, 1105 AZ Amsterdam, The NetherlandsLaboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam UMC Location University of Amsterdam, 1105 AZ Amsterdam, The NetherlandsLaboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam UMC Location University of Amsterdam, 1105 AZ Amsterdam, The NetherlandsDepartment of Pulmonary Medicine, Amsterdam UMC Location VU University Medical Center, 1081 HV Amsterdam, The NetherlandsLaboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam UMC Location University of Amsterdam, 1105 AZ Amsterdam, The NetherlandsLaboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam UMC Location University of Amsterdam, 1105 AZ Amsterdam, The NetherlandsDepartment of Pulmonary Medicine, Amsterdam UMC Location University of Amsterdam, 1105 AZ Amsterdam, The NetherlandsLaboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam UMC Location University of Amsterdam, 1105 AZ Amsterdam, The NetherlandsPancreatic Ductal Adenocarcinoma (PDAC) is among the most aggressive human cancers and occurs globally at an increasing incidence. Metastases are the primary cause of cancer-related death and, in the majority of cases, PDAC is accompanied by metastatic disease at the time of diagnosis, making it a particularly lethal cancer. Regrettably, to date, no curative treatment has been developed for patients with metastatic disease, resulting in a 5-year survival rate of only 11%. We previously found that the protein expression of the transcription factor CCAAT/Enhancer-Binding Protein Delta (C/EBPδ) negatively correlates with lymph node involvement in PDAC patients. To better comprehend the etiology of metastatic PDAC, we explored the role of C/EBPδ at different steps of the metastatic cascade, using established in vitro models. We found that C/EBPδ has a major impact on cell motility, an important prerequisite for tumor cells to leave the primary tumor and to reach distant sites. Our data suggest that C/EBPδ induces downstream pathways that modulate actin cytoskeleton dynamics to reduce cell migration and to induce a more epithelial-like cellular phenotype. Understanding the mechanisms dictating epithelial and mesenchymal features holds great promise for improving the treatment of PDAC.https://www.mdpi.com/2073-4409/11/21/3334CCAAT/enhancer-binding protein deltapancreatic ductal adenocarcinomametastasesmigrationcytoskeleton
spellingShingle Leonie Hartl
Pien A. F. Maarschalkerweerd
Joe M. Butler
Xue D. Manz
Victor L. J. L. Thijssen
Maarten F. Bijlsma
JanWillem Duitman
C. Arnold Spek
C/EBPδ Suppresses Motility-Associated Gene Signatures and Reduces PDAC Cell Migration
Cells
CCAAT/enhancer-binding protein delta
pancreatic ductal adenocarcinoma
metastases
migration
cytoskeleton
title C/EBPδ Suppresses Motility-Associated Gene Signatures and Reduces PDAC Cell Migration
title_full C/EBPδ Suppresses Motility-Associated Gene Signatures and Reduces PDAC Cell Migration
title_fullStr C/EBPδ Suppresses Motility-Associated Gene Signatures and Reduces PDAC Cell Migration
title_full_unstemmed C/EBPδ Suppresses Motility-Associated Gene Signatures and Reduces PDAC Cell Migration
title_short C/EBPδ Suppresses Motility-Associated Gene Signatures and Reduces PDAC Cell Migration
title_sort c ebpδ suppresses motility associated gene signatures and reduces pdac cell migration
topic CCAAT/enhancer-binding protein delta
pancreatic ductal adenocarcinoma
metastases
migration
cytoskeleton
url https://www.mdpi.com/2073-4409/11/21/3334
work_keys_str_mv AT leoniehartl cebpdsuppressesmotilityassociatedgenesignaturesandreducespdaccellmigration
AT pienafmaarschalkerweerd cebpdsuppressesmotilityassociatedgenesignaturesandreducespdaccellmigration
AT joembutler cebpdsuppressesmotilityassociatedgenesignaturesandreducespdaccellmigration
AT xuedmanz cebpdsuppressesmotilityassociatedgenesignaturesandreducespdaccellmigration
AT victorljlthijssen cebpdsuppressesmotilityassociatedgenesignaturesandreducespdaccellmigration
AT maartenfbijlsma cebpdsuppressesmotilityassociatedgenesignaturesandreducespdaccellmigration
AT janwillemduitman cebpdsuppressesmotilityassociatedgenesignaturesandreducespdaccellmigration
AT carnoldspek cebpdsuppressesmotilityassociatedgenesignaturesandreducespdaccellmigration